Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

HIF-1α Promotes Cbfbeta-SMMHC-Induced Acute Myeloid Leukemia Development

Benedikt W. Pelzer, Anita Hollenbeck, PhD, Stefanie Weber, Bertram Opalka, PhD, Lucio H. Castilla, PhD, Ulrich Dührsen, MD, Joachim R. Göthert, MD

Blood (2016) 128 (22): 1559.

https://doi.org/10.1182/blood.V128.22.1559.1559

Published: 2016

Journal Articles

The Role of Whole-Body Magnetic Resonance Imaging (WB-MRI) in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Ferras Alashkar, MD, Haemi Schemuth, MD, Felix Nensa, MD, Ulrich Dührsen, MD, Thomas Wilfried Schlosser, MD, Alexander Röth, MD

Blood (2016) 128 (22): 1271.

https://doi.org/10.1182/blood.V128.22.1271.1271

Published: 2016

Journal Articles

the Role of MSCs in the Development of Acute Myeloid Leukemia

Yahya Saleh Al-Matary, MSc, Lacramioara Botezatu, PhD, Robert Fernando Lams, Aniththa Thivakaran, MSc, Renata Köster, Judith Schütte, PhD, Ulrich Dührsen, MD, Bertram Opalka, PhD, Cyrus Khandanpour, MD

Blood (2016) 128 (22): 2669.

https://doi.org/10.1182/blood.V128.22.2669.2669

Published: 2016

Journal Articles

GFI1b As a Novel Oncosuppressor in AML

Aniththa Thivakaran, M.Sc., Lacramioara Botezatu, PhD, Judith Maria Hoenes, M.Sc., Yahya Saleh Al-Matary, MSc, Nadine Olberding, B.Sc, Judith Schütte, PhD, Renata Köster, Bertram Opalka, PhD, Ulrich Dührsen, MD, Cyrus Khandanpour, MD

Blood (2016) 128 (22): 2717.

https://doi.org/10.1182/blood.V128.22.2717.2717

Published: 2016

Journal Articles

Complement Inhibition with Eculizumab in Patients with Cold Agglutinin Disease (CAD): Results from a Prospective Phase II Trial (DECADE Trial)

Alexander Röth, MD, Martin Bommer, MD, Andreas Hüttmann, MD, Dörte Herich-Terhürne, Nils Kuklik, PhD, Lenz Veronika, Hubert Schrezenmeier, MD, Ulrich Dührsen, MD

Blood (2015) 126 (23): 274.

https://doi.org/10.1182/blood.V126.23.274.274

Published: 2015

Journal Articles

Persisting Hyperbilirubinemia in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Chronically Treated with Eculizumab: The Role of Hepatocanalicular Transport Variants

Ferras Alashkar, MD, Ali Canbay, MD, Dörte Herich-Terhürne, Ulrich Dührsen, MD, Frank Lammert, MD, Alexander Röth, MD

Blood (2015) 126 (23): 940.

https://doi.org/10.1182/blood.V126.23.940.940

Published: 2015

Journal Articles

Response to Rituximab Induction Is a Predictive Biomarker in Post-Transplant Lymphoproliferative Disorder (PTLD) and Allows Successful Treatment Stratification in an International Phase II Trial Including 152 Patients

Blood (2015) 126 (23): 816.

https://doi.org/10.1182/blood.V126.23.816.816

Published: 2015

Journal Articles

Immunoglobulin M Heavy/Light Chain Pair Measurement Independently Predicts Clinical Outcome and Refines Prognostic Information Provided By Interim PET in Patients with Aggressive Lymphomas

Patricia Johansson, MD, Jan Dürig, MD, Jan Rekowski, Dipl.-Stat., Stefan P Müller, MD, Bernd Hertenstein, MD, Christiane Franzius, MD, Frank Kroschinsky, MD, Jörg Kotzerke, MD, Rolf Mesters, MD, Matthias Weckesser, MD, Paul La Rosée, Prof. Dr. MD, Martin Freesmeyer, MD, Stefan Wilop, MD, Thomas Krohn, MD, Ulrich Dührsen, MD, Andreas Hüttmann, MD

Blood (2015) 126 (23): 3880.

https://doi.org/10.1182/blood.V126.23.3880.3880

Published: 2015

Journal Articles

Outcomes of Primary and Secondary Transformed B-Cell Lymphomas

Sedat Demirdas, Lewin Eisele, MD, Jörg Hense, MD, Ulrich Dührsen, MD, Andreas Hüttmann, MD

Blood (2015) 126 (23): 3894.

https://doi.org/10.1182/blood.V126.23.3894.3894

Published: 2015

Journal Articles

Activation of the Hypoxia-Inducible Factor Pathway Expands Early Thymic Progenitors

Anita Hollenbeck, Stefanie Weber, Kathrin Händschke, PhD, Mandy Necke, Bertram Opalka, PhD, Ulrich Dührsen, MD, Joachim Rudolf Göthert, MD

Blood (2014) 124 (21): 2896.

https://doi.org/10.1182/blood.V124.21.2896.2896

Published: 2014

Journal Articles

Functional Inhibition of Mesenchymal Stem and Progenitor Cells (MSPC) Significantly Contributes to Hematopoietic Insufficiency with Acute Myeloid Leukemia (AML)

Stefanie Geyh, Manuel Rodríguez-Paredes, Cyrus Khandanpour, MD, Ron-Patrick Cadeddu, Paul Jäger, Christoph Zilkens, Ulrich Dührsen, MD, C. Matthias Wilk, Roland Fenk, MD, Norbert Gattermann, MD PhD, Ulrich Germing, Guido Kobbe, MD, Frank Lyko, PhD, Rainer Haas, MD, Thomas Schroeder, MD

Blood (2014) 124 (21): 3492.

https://doi.org/10.1182/blood.V124.21.3492.3492

Published: 2014

Journal Articles

Effect of Age on Efficacy and Safety Outcomes in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Receiving Lenalidomide and Low-Dose Dexamethasone (Rd): The First Trial

Blood (2014) 124 (21): 81.

https://doi.org/10.1182/blood.V124.21.81.81

Published: 2014

Journal Articles

Preclinical Testing Of a Novel Axl-Kinase Inhibitor In Chronic Lymphocytic Leukemia

Maria Göbel, Michael Möllmann, André Görgens, PhD, Ulrich Dührsen, MD, Joachim Rudolf Göthert, MD, Bernd Giebel, Carsten Schultz-Fademrecht, Anke Unger, Bert Klebl, Axel Choidas, Jan Dürig, MD

Blood (2013) 122 (21): 2879.

https://doi.org/10.1182/blood.V122.21.2879.2879

Published: 2013

Journal Articles

Gfi1 As a Novel Prognostic Marker and Tumor Suppressor In Acute Myeloid Leukemia

Blood (2013) 122 (21): 2516.

https://doi.org/10.1182/blood.V122.21.2516.2516

Published: 2013

Journal Articles

Gfi1b-A Novel Tumor Suppressor In Acute Myeloid Leukemia

Lacramioara Botezatu, Phd, Judith Hönes, M.Sc., Amos Zeller, Lars C. Michel, Andre Görgens, Phd, Klaus Lennartz, Renata Köster, Bertram Opalka, PhD, Bernd Giebel, Ulrich Dührsen, MD, Cyrus Khandanpour, M.D.

Blood (2013) 122 (21): 3795.

https://doi.org/10.1182/blood.V122.21.3795.3795

Published: 2013

Journal Articles

Clonal Abundance Determines The Prognostic Relevance Of a NOTCH1 Mutation In Chronic Lymphocytic Leukemia

Stefanie Rost, Michael Möllmann, Lewin Eisele, MD, Stefanie Weber, Ulrich Dührsen, MD, Jan Dürig, MD, Joachim Rudolf Göthert, MD

Blood (2013) 122 (21): 2863.

https://doi.org/10.1182/blood.V122.21.2863.2863

Published: 2013

Journal Articles

Deletion Of The Von Hippel-Lindau Gene Interferes With The Development Of Peripheral B-Cell Subsets

Kathrin Händschke, Stefanie Weber, Mandy Necke, Anita Hollenbeck, Bertram Opalka, PhD, Ulrich Dührsen, MD, Joachim Rudolf Göthert, MD

Blood (2013) 122 (21): 3666.

https://doi.org/10.1182/blood.V122.21.3666.3666

Published: 2013

Journal Articles

A Randomized Trial Of Daily Prednisone Versus Pulsed Dexamethasone In Treatment Naïve Patients With Idiopathic Thrombocytopenic Purpura

Johannes Matschke, MD, Hannes Müller-Beißenhirtz, MD, Ilona Vester, Bernd Hertenstein, MD, Lewin Eisele, MD, Hildegard Lax, Claudia Ose, Ulrich Dührsen, MD

Blood (2013) 122 (21): 325.

https://doi.org/10.1182/blood.V122.21.325.325

Published: 2013

Journal Articles

Diffuse Large B-Cell Lymphoma (DLBCL) Patients Failing Second-Line R-DHAP Or R-ICE Chemotherapy Included In The Coral Study

Eric Van Den Neste, MD, PhD, Christian Gisselbrecht, MD, Norbert Schmitz, Nicolas Mounier, MD, PhD, Devinder S Gill, David Linch FMedSci, Marek Trneny, MD, Ph.D.,, Noel Milpied, MD, PhD, John Radford, MD, Nicolas Ketterer, Ofer Shpilberg, MD, MPH, Ulrich Dührsen, MD, David Ma, MD, Josette Brière, MD, Catherine Thieblemont, MD, PhD, Gilles Andre Salles, MD, PhD, Craig H. Moskowitz, MD, Bertram Glass

Blood (2013) 122 (21): 764.

https://doi.org/10.1182/blood.V122.21.764.764

Published: 2013

Journal Articles

An Observational Study of Anaemia Management in Patients with NHL Receiving CHOP-14 or -21 (With or Without Rituximab)

Gregor Verhoef, MD, Hans E Johnsen, MD, Francesca Gaia Rossi, MD, Antonio Salar, MD, PhD, Lisa Hamilton, MSc, W. Marieke Schoonen, PhD, Beatriz Pujol, PhD, Ulrich Duhrsen, MD

Blood (2008) 112 (11): 4948.

https://doi.org/10.1182/blood.V112.11.4948.4948

Published: 2008

NARROW

HIF-1α Promotes Cbfbeta-SMMHC-Induced Acute Myeloid Leukemia Development

The Role of Whole-Body Magnetic Resonance Imaging (WB-MRI) in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

the Role of MSCs in the Development of Acute Myeloid Leukemia

GFI1b As a Novel Oncosuppressor in AML

Complement Inhibition with Eculizumab in Patients with Cold Agglutinin Disease (CAD): Results from a Prospective Phase II Trial (DECADE Trial)

Persisting Hyperbilirubinemia in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Chronically Treated with Eculizumab: The Role of Hepatocanalicular Transport Variants

Response to Rituximab Induction Is a Predictive Biomarker in Post-Transplant Lymphoproliferative Disorder (PTLD) and Allows Successful Treatment Stratification in an International Phase II Trial Including 152 Patients

Immunoglobulin M Heavy/Light Chain Pair Measurement Independently Predicts Clinical Outcome and Refines Prognostic Information Provided By Interim PET in Patients with Aggressive Lymphomas

Outcomes of Primary and Secondary Transformed B-Cell Lymphomas

Activation of the Hypoxia-Inducible Factor Pathway Expands Early Thymic Progenitors

Functional Inhibition of Mesenchymal Stem and Progenitor Cells (MSPC) Significantly Contributes to Hematopoietic Insufficiency with Acute Myeloid Leukemia (AML)

Effect of Age on Efficacy and Safety Outcomes in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Receiving Lenalidomide and Low-Dose Dexamethasone (Rd): The First Trial

Preclinical Testing Of a Novel Axl-Kinase Inhibitor In Chronic Lymphocytic Leukemia

Gfi1 As a Novel Prognostic Marker and Tumor Suppressor In Acute Myeloid Leukemia

Gfi1b-A Novel Tumor Suppressor In Acute Myeloid Leukemia

Clonal Abundance Determines The Prognostic Relevance Of a NOTCH1 Mutation In Chronic Lymphocytic Leukemia

Deletion Of The Von Hippel-Lindau Gene Interferes With The Development Of Peripheral B-Cell Subsets

A Randomized Trial Of Daily Prednisone Versus Pulsed Dexamethasone In Treatment Naïve Patients With Idiopathic Thrombocytopenic Purpura

Diffuse Large B-Cell Lymphoma (DLBCL) Patients Failing Second-Line R-DHAP Or R-ICE Chemotherapy Included In The Coral Study

An Observational Study of Anaemia Management in Patients with NHL Receiving CHOP-14 or -21 (With or Without Rituximab)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only